INTRODUCTION
Increasing incidences of neurological complications are being encountered with the increase in the incidence of human immunodeficiency virus (HIV). [1] These can be due to the direct involvement of the central nervous system (CNS) by the virus or due to other opportunistic infections. Cerebral toxoplasmosis is a common opportunistic infection seen in HIV-infected patients, but it has rarely been encountered before the diagnosis of HIV infection is established. [1] We report a case of altered mental status secondary to acute Toxoplasma gondii encephalitis.
CASE
The patient was a 34-year-old man admitted to the emergency department with fever and altered mental status progressing for two days. His complaints began 7 days before with mild headache; after that he experienced progressive confusion, vomiting and a generalized tonic clonic seizure. The patient's mother denied any major illness, substance abuse or hospitalization of her son in the past, but pointed to one episode of suspicious seizure about 11 months ago, which had not been investigated.
On physical examination the patient was lethargic and quite ill. Upon admission to the emergency department, his body temperature was 38.5 ºC, blood pressure 110/70 mmHg, heart rate 102 beats/minute, respiratory rate 22/minute and oxygen saturation of 94% on room air. Bedside serum glucose level was 98 mg/dL. A focused neurologic exam highlighted drowsiness and time, place and person disorientation, but no focal deficits. The cranial nerves were intact and the patient was able to move all four extremities without limitation. Deep tendon reflexes were normal and there was no ataxia and neck stiffness present. Pupils were midsize and reactive. Limbs exam revealed no skin rash or track marks. Other systems, including cardiac, respiratory, abdominal, and genitourinary examination, were normal. A CT scan of the brain showed hydrocephalus and a hypodense lesion in the midbrain ( Figure 1 ). Primary laboratory workup revealed a normal complete blood count, normal electrolytes, negative urine drug screen and a mildly elevated erythrocyte sedimentation rate (23 mm/hour). The cerebrospinal fluid (CSF) was clear with a protein concentration of 1.08 g/L and a glucose concentration of 4.2 mmol/L. There was no bacterial growth after 48 hours of incubation.
He was started on Phenytoin for seizure prophylaxis, and empiric treatment with Metronidazole and Cefotaxime for possible brain abscess, but he did not respond to treatment. Fever and altered mental status did not improve; so, other causes of ring enhanced brain lesions were investigated. The patient immune system was checked. Rapid HIV antibody test was requested, which revealed a positive result. CD4 count was 186 cell/mm 3 and subsequent testing confi rmed HIV infection, but anti-toxoplasma IgG and IgM were negative. For further assessment, MRI was performed (Figure 2A and 2B) and showed a ring-enhancing lesion with edema in the left tectal plate of midbrain. Nevertheless, after the infectious disease specialist counselling, the patient was treated with Pyrimethamine, Sulfadiazine, Folic acid and Dexamethasone for cerebral toxoplasmosis. After 6 days of treatment with antitoxoplasmosis therapy, he responded well to the treatment with good neurological recovery and was discharged in two weeks with oral anti-toxoplasmosis regimen and was referred to his primary care physician. Antiretroviral therapy was to be initiated as an outpatient.
After normal mental status recovery, the patient revealed previous IV drug abuse, which he quit two years before. A follow-up MRI after three weeks showed decreased size of lesion and brain edema; subsequently, IgG for toxoplasma was repeated which had a positive result.
DISCUSSION
Neurological manifestations of HIV can occur at any time from viral acquisition to the late stages of AIDS; they are varied and may affect any part of the nervous system including the brain, spinal cord, autonomous nervous system and the peripheral nerves. HIV affects the nervous system in 70%-80% of infected patients. [2] The effect may be due to the direct effect of the virus, opportunistic infections and/or malignancies.
Toxoplasma encephalitis is the neurological disorder most frequently found in HIV/AIDS patients. [3] CT scan of the brain reveals multiple, bilateral, hypodense, contrast-enhancing brain lesions in the majority of patients. Toxoplasma encephalitis may less frequently present with a single lesion or with no lesions on CT scan. MRI is more sensitive than CT scan and thus is the preferred imaging technique. [4] MRI shows that around 70% of cerebral toxoplasmosis lesions are multifocal. Although considered rare, single lesion may be present in 14% to 17% of AIDS patients. [5] Patients with toxoplasma encephalitis typically exhibit rapid improvement after initiation of appropriate therapy. Neurologic response is noted in 51% of patients by day 3, and in 91% of patients by day 14. [6] Most patients will also experience radiologic improvement by the third week of treatment. [7, 8] Therefore, neuroradiologic study should be repeated 2-4 weeks after initiation of therapy.
CONCLUSION
There are some teaching points in this case, which can be interesting and useful for emergency physicians:
1) Patients with Toxoplasma encephalitis may have only one lesion or no obvious lesion on CT scan.
2) A negative IgG test result makes the diagnosis very unlikely but does not rule it out. [9] Toxoplasmaspecific IgG antibody levels in AIDS patients often are low to moderate, but occasionally no specific IgG antibodies can be detected. Tests for IgM antibodies are generally negative. If the patient has clinical illness compatible with toxoplasmosis but the IgG titer is low, a follow-up titer two to three weeks later should show an increase in antibody titer if the illness is due to acute toxoplasmosis, assuming the host is not severely immunocompromised. [10] 3) Toxoplasma gondii can affect any part of the brain.
4) CNS toxoplasmosis presenting as hydrocephalus is a very rare entity. [11] 5) Neurological illnesses are the initial manifestation of AIDS in 7% to 20% of patients. [12] So the history of AIDS is not always clear.
Hence, clinicians must consider this possibility before a ring-enhancing space-occupying cerebral lesion, even in patients without prior immunosuppression or an HIV infection history, in order to accomplish early diagnosis and proper treatment administration.
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